Primary prevention of VT/VF in patients with ICM and LVEF > 35% | Class | References |
---|---|---|
ICM substrate and ischaemic triggers for VT/VF must be evaluated when appropriate (coronary angiogram, functional ischaemic evaluation by nuclear scan, stress-echocardiography or MRI). | 54 , 70 , 71 | |
EPS and non-sustained VT evaluation could be considered to improve VT/VF risk stratification in patients with relatively preserved LVEF, particularly in the convalescent phase (first 2 months) after an acute coronary syndrome. | 311 , 373 , 374 | |
Heart rate variability (HRV), LVP, baroreflex sensitivity, QT-interval dispersion, T-wave alternans and heart rate turbulence have not been evaluated adequately in this population for generalized use. | 73 , 371 , 372 |